Company: CERO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001213900-25-010230
Chunk: 256

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 256
---
| (2) | Reflects                                                                                                                                    
 the weighted-average exercise price of the $10.00 outstanding stock options under the 2024 Plan and 2016 Plan, presented on an as-converted 
 basis.                                                                                                                                      |

| On                                                                                                                                      
 February 8, 2024, the stockholders approved the 2024 Plan and 2024 ESPP, with an initial reserve of 51,726 and 5,272 shares of common   
 stock, respectively. The 2024 Plan and 2024 ESPP became effective on February 14, 2024 in connection with the closing of the Business   
 Combination. At a special meeting of stockholders on April 30, 2024, the stockholders approved an increase in the number of shares      
 available for issuance under the 2024 Plan and the number of shares that may be issued pursuant to incentive stock options, by an       
 additional 20,000 shares each. At a special meeting of stockholders on November 11, 2024, the stockholders approved an increase in      
 the number of shares available for issuance under the 2024 Plan and the number of shares that may be issued pursuant to incentive       
 stock options, by an additional 208,454 shares each. As of January 8, 2025, no awards have been granted under the 2024 ESPP. No new     
 awards may be granted under the 2016 Plan, but all outstanding awards under the 2016 Plan continue to be governed by their existing     
 terms. The 2024 Plan has an evergreen provision that allows for an annual increase in the number of shares available for issuance       
 under the 2024 Plan to be added on the first day of January, starting with January 1, 2025, in an amount equal to the lesser of (i)     
 5% of the fully diluted shares of our common stock on the immediately preceding December 31 or (ii) such number of shares as determined 
 by our board in each case subject to adjustment in the event of a stock split, stock dividend or other change in our capitalization.    
 On January 1, 2025, the number of shares reserved under the 2024 Plan was increased by 5% of the fully diluted shares of our common     
 stock on the immediately preceding December 31, or 189,701 shares. The 2024 ESPP has an evergreen provision that allows for an annual   
 increase in the number of shares available for issuance under the